Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Crystal Natural Pharmaceutical is a specialized pharmaceutical company based in Kunming, China, focusing on the development and production of natural medicines and traditional Chinese medicine (TCM). The company is renowned for its utilization of Yunnan's unique botanical resources, particularly the herb Erigeron breviscapus, to create treatments for cardiovascular and cerebrovascular ailments. Their flagship products, such as Dengzhan Shengmai capsules and Dengzhanxixin injections, are widely used in China for managing conditions like ischemic stroke and coronary heart disease. The firm integrates modern extraction technologies with traditional pharmacological knowledge to produce standardized, high-quality therapeutic agents. Operating under strict Good Manufacturing Practice (GMP) standards, the company maintains a robust manufacturing and distribution network within the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Crystal Natural Pharmaceutical.